GLP
GLP-1 Medications and Mental Health: What to Expect and When to Get Support
Most of what gets written about GLP-1 medications covers the body. Dosing, appetite, nausea, what to eat, what to expect on the scale. Less…
Mons Pubis Fat Loss on GLP-1s: The “Pubic Area” Change Nobody Mentions
One change that surprises people on GLP-1 medications rarely comes up in conversation: the mons pubis, the soft fat pad over the pubic bone,…
How to Adjust Weight Loss Goals on GLP-1 Medications
Adjust weight goals on GLP-1 meds by tracking body composition and labs, optimizing protein, activity, sleep, and working with your provider on dosing.
Falsified Mounjaro pens prompt urgent safety advisory
MHRA warns of counterfeit Mounjaro pens (batch D873576); stop use and check batch numbers for infection risk.
What is GLP in a Laboratory? The Full 2026 Breakdown
Confused about GLP in a lab? We explain what is GLP in laboratory science, from quality regulations to the GLP-1 medications changing lives in 2026.
What is a GLP Treatment? The 2026 Expert Breakdown
Wondering what a GLP treatment is? Our medical experts break down the science behind these revolutionary medications for metabolic health in 2026.
Novo Nordisk shares drop as Alzheimer’s hopes for weight-loss drug fade
Novo Nordisk’s semaglutide failed to slow Alzheimer’s in large trials, prompting shares to fall and expert reactions.
China’s Supreme Court Upholds Semaglutide Patent for Novo Nordisk
China’s Supreme People’s Court upholds Novo Nordisk’s semaglutide compound patent, supporting IP protection.
Over 600,000 Californians Risk Losing Access to GLP-1 Weight-Loss Drugs
California’s Medi-Cal will stop covering GLP-1 weight-loss drugs for weight-loss-only prescriptions, effective Jan. 1, 2026.
